vs
Profound Medical Corp.（PROF）与华米科技（ZEPP）财务数据对比。点击上方公司名可切换其他公司
华米科技的季度营收约是Profound Medical Corp.的1.7倍（$10.5M vs $6.0M），华米科技净利率更高（-2.1% vs -136.8%，领先134.6%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
华米科技（Zepp Health）是全球知名的智能可穿戴设备与数字健康解决方案提供商，核心产品包括智能手表、运动手环、AI健康监测工具，面向个人消费者、体育机构及医疗合作伙伴，提供健康追踪、远程健康管理等服务。
PROF vs ZEPP — 直观对比
营收规模更大
ZEPP
是对方的1.7倍
$6.0M
净利率更高
ZEPP
高出134.6%
-136.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $10.5M |
| 净利润 | $-8.2M | $-223.0K |
| 毛利率 | 66.8% | 38.2% |
| 营业利润率 | -123.3% | -1.2% |
| 净利率 | -136.8% | -2.1% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.27 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFZEPP
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.1M | $10.5M | ||
| Q2 25 | $2.0M | $8.2M | ||
| Q1 25 | $2.3M | $5.3M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $5.6M | ||
| Q1 24 | — | $5.5M | ||
| Q3 23 | — | $11.4M |
净利润PROFZEPP
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-8.0M | $-223.0K | ||
| Q2 25 | $-15.7M | $-1.1M | ||
| Q1 25 | $-10.7M | $-2.7M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-2.0M | ||
| Q3 23 | — | $52.6K |
毛利率PROFZEPP
| Q4 25 | 66.8% | — | ||
| Q3 25 | 77.7% | 38.2% | ||
| Q2 25 | 81.7% | 36.2% | ||
| Q1 25 | 79.2% | 37.3% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 36.8% | ||
| Q3 23 | — | 33.9% |
营业利润率PROFZEPP
| Q4 25 | -123.3% | — | ||
| Q3 25 | -176.2% | -1.2% | ||
| Q2 25 | -696.9% | -10.3% | ||
| Q1 25 | -477.0% | -47.7% | ||
| Q3 24 | — | -29.5% | ||
| Q2 24 | — | -24.3% | ||
| Q1 24 | — | -39.6% | ||
| Q3 23 | — | — |
净利率PROFZEPP
| Q4 25 | -136.8% | — | ||
| Q3 25 | -157.7% | -2.1% | ||
| Q2 25 | -792.3% | -13.0% | ||
| Q1 25 | -458.1% | -51.2% | ||
| Q3 24 | — | -31.2% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -36.8% | ||
| Q3 23 | — | 0.5% |
每股收益（稀释后）PROFZEPP
| Q4 25 | $0.27 | — | ||
| Q3 25 | $0.26 | $-0.01 | ||
| Q2 25 | $0.52 | $-0.07 | ||
| Q1 25 | $0.36 | $-0.17 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.01 | ||
| Q3 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $8.7M |
| 总债务越低越好 | $4.5M | $9.6M |
| 股东权益账面价值 | $66.4M | $31.2M |
| 总资产 | $77.5M | $80.9M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.31× |
8季度趋势，按日历期对齐
现金及短期投资PROFZEPP
| Q4 25 | $59.7M | — | ||
| Q3 25 | $24.8M | $8.7M | ||
| Q2 25 | $35.2M | $7.8M | ||
| Q1 25 | $46.4M | $10.7M | ||
| Q3 24 | — | $16.4M | ||
| Q2 24 | — | $17.0M | ||
| Q1 24 | — | $17.9M | ||
| Q3 23 | — | $17.9M |
总债务PROFZEPP
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | $9.6M | ||
| Q2 25 | $4.5M | $9.7M | ||
| Q1 25 | $4.5M | $9.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $11.2M | ||
| Q3 23 | — | $16.3M |
股东权益PROFZEPP
| Q4 25 | $66.4M | — | ||
| Q3 25 | $32.1M | $31.2M | ||
| Q2 25 | $39.3M | $31.1M | ||
| Q1 25 | $50.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $44.6M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $48.0M |
总资产PROFZEPP
| Q4 25 | $77.5M | — | ||
| Q3 25 | $42.3M | $80.9M | ||
| Q2 25 | $49.7M | $75.8M | ||
| Q1 25 | $60.9M | $71.6M | ||
| Q3 24 | — | $81.3M | ||
| Q2 24 | — | $79.7M | ||
| Q1 24 | — | $80.5M | ||
| Q3 23 | — | $91.4M |
负债/权益比PROFZEPP
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | 0.31× | ||
| Q2 25 | 0.11× | 0.31× | ||
| Q1 25 | 0.09× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PROFZEPP
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-9.6M | — | ||
| Q2 25 | $-13.7M | — | ||
| Q1 25 | $-8.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
